323 related articles for article (PubMed ID: 15472814)
1. Clinical efficacy of intramuscular vaccinia immune globulin: a literature review.
Hopkins RJ; Lane JM
Clin Infect Dis; 2004 Sep; 39(6):819-26. PubMed ID: 15472814
[TBL] [Abstract][Full Text] [Related]
2. Smallpox vaccination reactions, prophylaxis, and therapy of complications.
Goldstein JA; Neff JM; Lane JM; Koplan JP
Pediatrics; 1975 Mar; 55(3):342-7. PubMed ID: 238178
[TBL] [Abstract][Full Text] [Related]
3. Smallpox vaccination and adverse reactions. Guidance for clinicians.
Cono J; Casey CG; Bell DM;
MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
[TBL] [Abstract][Full Text] [Related]
4. Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteers.
Hopkins RJ; Kramer WG; Blackwelder WC; Ashtekar M; Hague L; Winker-La Roche SD; Berezuk G; Smith D; Leese PT
Clin Infect Dis; 2004 Sep; 39(6):759-66. PubMed ID: 15472804
[TBL] [Abstract][Full Text] [Related]
5. Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy.
Wittek R
Int J Infect Dis; 2006 May; 10(3):193-201. PubMed ID: 16564720
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy discovered after smallpox vaccination: Is vaccinia immune globulin appropriate?
Napolitano PG; Ryan MA; Grabenstein JD
Am J Obstet Gynecol; 2004 Dec; 191(6):1863-7. PubMed ID: 15592266
[TBL] [Abstract][Full Text] [Related]
7. Ocular complications in the Department of Defense Smallpox Vaccination Program.
Fillmore GL; Ward TP; Bower KS; Dudenhoefer EJ; Grabenstein JD; Berry GK; Madigan WP
Ophthalmology; 2004 Nov; 111(11):2086-93. PubMed ID: 15522376
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
Bell E; Shamim M; Whitbeck JC; Sfyroera G; Lambris JD; Isaacs SN
Virology; 2004 Aug; 325(2):425-31. PubMed ID: 15246280
[TBL] [Abstract][Full Text] [Related]
9. Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response.
Lustig S; Maik-Rachline G; Paran N; Melamed S; Israely T; Erez N; Orr N; Reuveny S; Ordentlich A; Laub O; Shafferman A; Velan B
Vaccine; 2009 Mar; 27(11):1691-9. PubMed ID: 19195492
[TBL] [Abstract][Full Text] [Related]
10. Complications of smallpox vaccination, 1968. Results of a statewide survey in Alaska.
Clark PS; Lane JM
Calif Med; 1971 Sep; 115(3):7-10. PubMed ID: 5094595
[TBL] [Abstract][Full Text] [Related]
11. Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963-1968.
Aragón TJ; Ulrich S; Fernyak S; Rutherford GW
BMC Public Health; 2003 Aug; 3():26. PubMed ID: 12911836
[TBL] [Abstract][Full Text] [Related]
12. Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin.
Jones-Trower A; Garcia A; Meseda CA; He Y; Weiss C; Kumar A; Weir JP; Merchlinsky M
Virology; 2005 Dec; 343(1):128-40. PubMed ID: 16165184
[TBL] [Abstract][Full Text] [Related]
13. Smallpox vaccine: contraindications, administration, and adverse reactions.
Maurer DM; Harrington B; Lane JM
Am Fam Physician; 2003 Sep; 68(5):889-96. PubMed ID: 13678138
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity.
He Y; Manischewitz J; Meseda CA; Merchlinsky M; Vassell RA; Sirota L; Berkower I; Golding H; Weiss CD
J Infect Dis; 2007 Oct; 196(7):1026-32. PubMed ID: 17763325
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel vaccinia-neutralization assay based on reporter-gene expression.
Manischewitz J; King LR; Bleckwenn NA; Shiloach J; Taffs R; Merchlinsky M; Eller N; Mikolajczyk MG; Clanton DJ; Monath T; Weltzin RA; Scott DE; Golding H
J Infect Dis; 2003 Aug; 188(3):440-8. PubMed ID: 12870127
[TBL] [Abstract][Full Text] [Related]
16. Selection of Vaccinia Virus-Neutralizing Antibody from a Phage-Display Human-Antibody Library.
Shin YW; Chang KH; Hong GW; Yeo SG; Jee Y; Kim JH; Oh MD; Cho DH; Kim SH
J Microbiol Biotechnol; 2019 Apr; 29(4):651-657. PubMed ID: 30856707
[TBL] [Abstract][Full Text] [Related]
17. Adverse events occurring after smallpox vaccination.
Lane JM; Goldstein J
Semin Pediatr Infect Dis; 2003 Jul; 14(3):189-95. PubMed ID: 12913830
[TBL] [Abstract][Full Text] [Related]
18. Henry Kempe and the birth of vaccinia immune globulin.
Bray M
Clin Infect Dis; 2004 Sep; 39(6):767-9. PubMed ID: 15472805
[No Abstract] [Full Text] [Related]
19. Postexposure prevention of progressive vaccinia in SCID mice treated with vaccinia immune globulin.
Fisher RW; Reed JL; Snoy PJ; Mikolajczyk MG; Bray M; Scott DE; Kennedy MC
Clin Vaccine Immunol; 2011 Jan; 18(1):67-74. PubMed ID: 21106779
[TBL] [Abstract][Full Text] [Related]
20. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
